Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ALP-KII

K-Number: K810008 · 1981-01-16

Decision Date1981-01-16
Product CodeDXQ
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

ALP-KII is the device name listed in this FDA 510(k) record. The listed applicant is Martin'S Maine Exchange. It received FDA 510(k) clearance on 1981-01-16 under 510(k) number K810008. The device is classified under product code DXQ. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ALP-KII?

ALP-KII is a medical device that received FDA 510(k) clearance on 1981-01-16. The listed applicant is Martin'S Maine Exchange. The 510(k) number is K810008.

When did ALP-KII receive FDA 510(k) clearance?

ALP-KII received FDA 510(k) clearance on 1981-01-16, under 510(k) number K810008.

Who is the listed applicant for ALP-KII?

The FDA 510(k) record lists Martin'S Maine Exchange as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ALP-KII?

The FDA product code for ALP-KII is DXQ.

Other records listing Martin'S Maine Exchange as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DXQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑